Ventas, Inc. (VTR) Operating Cash Flow CAGR:25.94%(TTM)
Operating cash flow CAGR uses precomputed cash-flow statement history (cash from operations, before capital expenditures).
Over longer horizons, Ventas, Inc.'s Operating Cash Flow CAGR averages 16.23% over 3 years and 5.01% over 5 years.The TTM figure compares the trailing 12 months (sum of the latest four quarters) with the 12 months before that. Rows in the history table compare fiscal years, and the quarterly table compares single quarters; the three measure different windows and will differ. Operating cash flow CAGR measures the compound annual growth rate of the cash Ventas, Inc. generates from its core business operations, before capital expenditures, computed from rolling-twelve-month cash-flow statement history.
VTR Operating Cash Flow CAGR Chart
Ventas, Inc. (VTR)
VTR Quarterly Operating Cash Flow Growth (YoY)
Operating Cash Flow growth vs the same quarter one year earlier, last 20 quarters.
VTR Operating Cash Flow CAGR History
| Year | Start OCF | End OCF | Change | % Change | CAGR |
|---|---|---|---|---|---|
| 2025 | $1.34B | $1.68B | +$342.43M | +25.59% | +25.59% |
| 2024 | $1.19B | $1.34B | +$143.45M | +12.01% | +12.01% |
| 2023 | $1.15B | $1.19B | +$46.07M | +4.01% | +4.01% |
| 2022 | $1.04B | $1.15B | +$104.51M | +10.01% | +10.01% |
| 2021 | $1.45B | $1.04B | $-406.21M | -28.01% | -28.01% |
| 2020 | $1.44B | $1.45B | +$12.22M | +0.85% | +0.85% |
| 2019 | $1.44B | $1.44B | $-967.00K | -0.07% | -0.07% |
| 2018 | $1.43B | $1.44B | +$4.00M | +0.28% | +0.28% |
| 2017 | $1.37B | $1.43B | +$67.46M | +4.93% | +4.93% |
| 2016 | $1.39B | $1.37B | $-24.31M | -1.75% | -1.75% |
| 2015 | $1.25B | $1.39B | +$136.92M | +10.91% | +10.91% |
| 2014 | $1.19B | $1.25B | +$60.09M | +5.03% | +5.03% |
| 2013 | $992.82M | $1.19B | +$201.94M | +20.34% | +20.34% |
| 2012 | $773.20M | $992.82M | +$219.62M | +28.40% | +28.40% |
| 2011 | $447.62M | $773.20M | +$325.57M | +72.73% | +72.73% |
| 2010 | $422.10M | $447.62M | +$25.52M | +6.05% | +6.05% |
| 2009 | $379.91M | $422.10M | +$42.19M | +11.11% | +11.11% |
| 2008 | $399.81M | $379.91M | $-19.90M | -4.98% | -4.98% |
| 2007 | $268.66M | $399.81M | +$131.15M | +48.82% | +48.82% |
| 2006 | $213.64M | $268.66M | +$55.01M | +25.75% | +25.75% |
| 2005 | $149.96M | $213.64M | +$63.69M | +42.47% | +42.47% |
| 2004 | $137.37M | $149.96M | +$12.59M | +9.17% | +9.17% |
| 2003 | $116.39M | $137.37M | +$20.98M | +18.03% | +18.03% |
| 2002 | $79.89M | $116.39M | +$36.49M | +45.68% | +45.68% |
| 2001 | $85.34M | $79.89M | $-5.45M | -6.38% | -6.38% |
| 2000 | $103.58M | $85.34M | $-18.24M | -17.61% | -17.61% |
| 1999 | $86.76M | $103.58M | +$16.82M | +19.39% | +19.39% |
| 1998 | $270.93M | $86.76M | $-184.17M | -67.98% | -67.98% |
| 1997 | $183.54M | $270.93M | +$87.39M | +47.61% | +47.61% |
Quarterly Operating Cash Flow: QoQ & YoY
| Quarter | Value | QoQ | YoY |
|---|---|---|---|
| Q1 2026 | $394.61M | -21.9% | +22.9% |
| Q4 2025 | $505.36M | +33.5% | +33.2% |
| Q3 2025 | $378.58M | -20.4% | +6.3% |
| Q2 2025 | $475.34M | +48.0% | +41.5% |
| Q1 2025 | $321.14M | -15.4% | +20.5% |
| Q4 2024 | $379.45M | +6.5% | +36.0% |
| Q3 2024 | $356.22M | +6.1% | -1.3% |
| Q2 2024 | $335.87M | +26.1% | +7.7% |
| Q1 2024 | $266.45M | -4.5% | +9.7% |
| Q4 2023 | $279.08M | -22.7% | +4.4% |
| Q3 2023 | $360.81M | +15.7% | +19.1% |
| Q2 2023 | $311.83M | +28.4% | +2.7% |
| Q1 2023 | $242.82M | -9.1% | -11.6% |
| Q4 2022 | $267.25M | -11.8% | +0.5% |
| Q3 2022 | $302.94M | -0.3% | +21.5% |
| Q2 2022 | $303.73M | +10.6% | +4.3% |
QoQ = change vs the prior quarter; YoY = change vs the same quarter a year earlier.
About Ventas, Inc.
As an S&P 500 company, Ventas operates strategically at the nexus of the dynamic healthcare and real estate industries. We stand as one of the world's foremost Real Estate Investment Trusts (REITs), utilizing financial capital to unlock property value. Our partnerships extend to leading care providers, developers, research and medical institutions, innovators, and healthcare organizations, all of whom benefit from the significant demographic trend of an aging population. For over two decades, Ventas has pursued a steadfast and effective strategy: maintaining a high-quality, diverse portfolio of assets and varied capital streams to skillfully navigate market fluctuations. A dedicated and experienced team collaborates with industry-leading partners to generate consistent, increasing cash flows and superior returns on a strong balance sheet, ultimately enriching Ventas's shareholders. As of September 30, 2020, Ventas either owned outright or managed through unconsolidated joint ventures approximately 1,200 properties.
- Sector
- Real Estate
- Industry
- REIT - Healthcare Facilities
- CEO
- Debra A. Cafaro